Some links on this page are affiliate links: if you buy through them we may earn a commission, at no extra cost to you.
Neurable announced on May 7, 2024, that it had raised an additional $13 million to develop non-invasive EEG-based brain-computer interface (BCI) technology for products such as headphones, earbuds and helmets. The company said the financing brought its funding since founding to more than $30 million. The round backed a plan to license its technology to device makers—not a general-purpose system for reading private thoughts.
What Neurable announced in 2024
The Boston-based company named Ultratech Capital Partners, TRAC, Pace Ventures and Metaplanet as investors. Its announcement described the $13 million as additional funding but did not identify a financing type, valuation or lead investor. Neurable said it would use the money to advance its BCI-AI platform, develop reference designs and enabled systems, and expand licensing to original-equipment manufacturers (OEMs).
The company’s stated cumulative total of more than $30 million was its own figure at the time of the May 2024 announcement. The release does not establish how the investment affected revenue, valuation or runway. Neurable’s funding announcement named headphones, earbuds, helmets and other head-worn devices as potential applications.
What Neurable’s brain-computer interface does
A BCI is a broad category of systems that use brain signals to support communication or interaction with a device. Neurable describes its platform as non-invasive: sensors in wearable headgear record electrical activity using electroencephalography (EEG), and signal processing and AI interpret patterns in those recordings. The company presents applications such as estimating focus or fatigue and providing feedback or device interaction. These are company-described capabilities, not proof that every product can reliably measure those states in everyday conditions. Neurable’s technology overview describes its approach.
#1 Best Overall
This is not the same as an implanted interface, which places electrodes inside the body. Nor does scalp EEG provide a direct transcript of a person’s thoughts. The proposition is narrower: infer selected patterns or states from signals that are indirect, variable and susceptible to noise.
Why put EEG in consumer products?
Neurable’s 2024 plan centered on licensing. Rather than manufacture every device itself, the company aimed to provide technology and integration support to OEMs, which could incorporate brain-sensing features into their own products. That approach could extend the platform into familiar devices and use partners’ manufacturing and distribution. It also means that the eventual experience—including sensors, software, support and data practices—may depend on the individual partner and product.
Rank #2
The commercial challenge is to make a signal-derived metric useful enough to justify the added sensors and setup. A focus score, for example, needs to be understandable and actionable, not merely available in an app. Compact wearables also face trade-offs: fewer or smaller sensors can make a device easier to wear, while fit, hair, movement, sweat, electrical interference and differences between people can affect the signal. Calibration may help but can add friction.
Quick wins for a faster PC:
Repair Windows errors before they cause bigger problemsFix Now →Scan for outdated or missing drivers - takes under a minuteDriver Scan →Clear out junk files and repair common Windows errorsFree Scan →The MW75 Neuro: a product, not proof of every claim
The most concrete consumer example tied to the financing is the MW75 Neuro, headphones developed with Master & Dynamic and designed to incorporate Neurable’s brain-sensing technology. The product was positioned around focus and cognitive performance, including fatigue-related feedback. Neurable’s newsroom timeline lists the MW75 Neuro as launched on September 24, 2024; the funding announcement had described it as upcoming.
Rank #3
The company’s product and launch materials establish that the headphones reached a launch announcement, but the available information here does not independently establish measurement accuracy, clinical value, productivity gains, long-term comfort or current retail availability. No current price or official buying page is established here either. The product should not be treated as a diagnostic device on the basis of its wellness or performance positioning.
What would make consumer EEG useful—and what remains uncertain
For a consumer BCI, the central question is not whether a wearable can detect brain-related electrical signals; it is whether its interpretation stays useful outside carefully controlled conditions. A credible product needs to explain what it measures, how it handles individual variation, and what a user can do with the result. Independent validation matters especially when marketing moves from a narrowly defined metric to broad claims about cognition or health.
Rank #4
- Signal quality: Head movement, sensor contact, fit, hair, sweat and ambient electrical noise can complicate EEG measurements.
- Interpretation: A company’s estimate of focus or fatigue is not automatically a clinical measurement or a universal score. The model’s validation and limits matter.
- User value: Feedback is more compelling when it helps a person make a concrete choice, such as taking a break or adjusting a training session.
- Wearability: Comfort, battery life, calibration time and compatibility with different heads, hair and glasses affect whether people will use a device regularly.
- Privacy: Brain-related data is sensitive. Buyers should look for clear answers on what is collected, where it is processed or stored, whether it is used to train models, how it can be deleted and whether partners or third parties can access it.
The funding announcement does not establish Neurable’s current data-retention or sharing practices across products. Those details need to be assessed in the terms and privacy materials for the specific device and its manufacturer. Likewise, a consumer wellness product is not thereby a medical device: medical or diagnostic claims require evidence and the relevant regulatory status.
What changed after the $13 million round
The 2024 financing is no longer Neurable’s latest reported funding event. TechCrunch reported in April 2026 that the company had raised a $35 million Series A in December 2025 and was pursuing consumer-wearable licensing in areas including health, athletics, productivity and gaming. The report also described potential form factors such as headphones, hats, glasses and headbands. These are later commercial plans, not evidence that each category has shipped. TechCrunch’s report is the source for the later funding and licensing details.
Best Value
- Learn about your brainwaves, train your meditation, and develop your own applications with the mindwave mobile wireless headset.
- Bt/ble Dual mode module and support iOS, Android, PC, and Mac platform. Detects raw-brainwaves, eeg power spectrums (Alpha, beta, etc.), esense meters for attention, meditation, and future algorithms.
- More than 100 brain training games and educational apps available from the NeuroSky online store. Uses a single AAA battery (not included) for 8-hour battery run time
The trajectory supports the view that Neurable is building a platform and partnership business around non-invasive brain sensing. Beyond the MW75 Neuro launch listing, the information available here does not confirm current retail availability or performance for the newer product categories. For consumers, the practical test remains whether a particular device produces reliable, useful feedback and explains how it handles sensitive data. For manufacturers, the opportunity is to add brain-sensing features to existing product lines; integration, validation and customer trust remain significant work.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
